(Q53655424)
Statements
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. (English)
1 reference
David Miller
1 reference
Paul O'Connor
1 reference
Katherine Riester
1 reference
Minhua Yang
1 reference
Michael Panzara
1 reference
Catherine Dalton
1 reference
Katherine Miszkiel
1 reference
Omar Khan
1 reference
George Rice
1 reference
William Sheremata
1 reference
International Natalizumab Trial Group
1 reference
1 October 2005
1 reference
11
1 reference
5
1 reference
568-572
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference